Clinical aspects and management of chronic itch

J Allergy Clin Immunol. 2023 Jul;152(1):1-10. doi: 10.1016/j.jaci.2023.04.018. Epub 2023 May 11.

Abstract

Chronic pruritus (CP) (ie, itch that persists for more than 6 weeks) poses significant challenges to patients' health and quality of life. It is a common reason for visits to dermatologists and general practitioners and can be caused by a range of conditions, including systemic diseases such as chronic kidney disease or liver diseases, malignancies, neuropathic conditions, and dermatoses such as atopic dermatitis. CP often does not develop in parallel with the course of the disease and can become an entity of its own, which must be treated with antipruritic drugs, even if the underlying cause is already under therapy. Depending on the etiology of CP, different pathways in the pathogenesis have been analyzed recently, following which new treatments have been developed and tested in randomized controlled trials. This article discusses the recent results of these studies and highlights how best to manage health care for patients with CP.

Keywords: Chronic pruritus; burden; chronic nodular prurigo; chronic prurigo; prurigo nodularis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipruritics
  • Chronic Disease
  • Dermatitis, Atopic* / complications
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Prurigo*
  • Pruritus / drug therapy
  • Pruritus / etiology
  • Quality of Life

Substances

  • Antipruritics